Filing Details
- Accession Number:
- 0001437749-20-019410
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-08 16:24:10
- Reporting Period:
- 2020-09-03
- Accepted Time:
- 2020-09-08 16:24:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1443669 | Proto Labs Inc | PRLB | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1181629 | M Victoria Holt | 5540 Pioneer Creek Drive Maple Plain MN 55359 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-09-03 | 17,990 | $67.15 | 76,449 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-09-03 | 4,266 | $152.43 | 72,183 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-09-03 | 2,617 | $153.69 | 69,566 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-09-03 | 3,219 | $154.45 | 66,347 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-09-03 | 3,158 | $155.50 | 63,189 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-09-03 | 2,330 | $156.60 | 60,859 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-09-03 | 1,200 | $157.81 | 59,659 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-09-03 | 400 | $159.19 | 59,259 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-09-03 | 800 | $161.14 | 58,459 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2020-09-03 | 17,990 | $0.00 | 17,990 | $67.15 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-02-09 | No | 4 | M | Direct |
Footnotes
- Stock option exercise and sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 4, 2020.
- Reflects the weighted average price of 4,266 shares of common stock of Proto Labs, Inc. sold by the reporting person on September 3, 2020 with sale prices ranging from $151.92 to $152.86 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average price of 2,617 shares of common stock of Proto Labs, Inc. sold by the reporting person on September 3, 2020 with sale prices ranging from $152.97 to $153.95 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average price of 3,219 shares of common stock of Proto Labs, Inc. sold by the reporting person on September 3, 2020 with sale prices ranging from $153.97 to $154.89 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average price of 3,158 shares of common stock of Proto Labs, Inc. sold by the reporting person on September 3, 2020 with sale prices ranging from $155.04 to $155.91 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average price of 2,330 shares of common stock of Proto Labs, Inc. sold by the reporting person on September 3, 2020 with sale prices ranging from $156.14 to $157.05 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average price of 1,200 shares of common stock of Proto Labs, Inc. sold by the reporting person on September 3, 2020 with sale prices ranging from $157.66 to $157.90 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Fully vested.
Billionaire Hedge Funds
